According to the results of the II generation, we compared the gene sequencing of 3326 bases of BRCA1 gene and the 1342 bases of BRCA2 gene in all females of the III generation in the family and 2 patients with sporadic serous ovarian cancer (control). The gene discussed is BRCA1; the disease is ovarian serous adenocarcinoma.